The results showed that in those patients that presented D-dimmer levels ≥ 1 mg/L, PTX3 levels significantly and positively correlated with the occurrence of coagulopathies and the COVID-19 disease severity. This evidence concerns the gene PTX3 and blood coagulation disease.